Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program (Q36915096)

From Wikidata
Jump to navigation Jump to search
scientific article published on 8 March 2016
edit
Language Label Description Also known as
English
Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
scientific article published on 8 March 2016

    Statements

    Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program (English)
    John E Mazuski
    Leanne B Gasink
    Jon Armstrong
    Helen Broadhurst
    Greg G Stone
    Douglas Rank
    Lily Llorens
    Paul Newell
    Jan Pachl
    8 March 2016
    1380-1389

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit